Nayyar Junaid, Bedu-Ferrari Cassandre, Patangia Dhrati, Hurley Eimear, Feeley Linda, Ross R Paul, Stanton Catherine, Brady Paul
Cork University Dental School & Hospital, Wilton, Co. Cork, T12 E8YV, Ireland.
Teagasc Food Research Centre, Moorepark, Co. Cork, P61 C996, Ireland.
J Dent. 2025 Sep;160:105848. doi: 10.1016/j.jdent.2025.105848. Epub 2025 May 31.
The human microbiome is widely known to be associated with health and disease. The oral microbiome has been linked with oral diseases and infections, though not many studies have explored the relation between oral and gut microbiome with oral cancer based on lesion histology METHODS: This study uniquely explores the oral and gut microbiota in 30 participants (n = 30) divided into three groups based on histology; Benign (B) (n = 15), Potentially Malignant (PM) (n = 8), and Malignant (M) (n = 7) oral lesions. Using shotgun metagenomic sequencing, we analysed microbiota profiles to determine their potential as biomarkers for oral malignancy RESULTS: Distinct gut microbial profiles were observed between Benign and Malignant groups and the association of specific microbes in oral saliva, such as Haemophilus parainfluenzae, Veillonella parvula, Fusobacterium nucleatum and Rothia mucilaginosa were strongly associated with malignancy CONCLUSION: The data from this exploratory study suggest that oral and gut microbiomes could act as possible biomarkers and aid in early detection and assessment of oral cancer risk. With regard to potentially malignant lesions, future research could study individual Oral Potentially Malignant Disorders (OPMDs) as distinct entities due to the wide variation in clinical and histological presentation. Further research is required to develop definitive biomarkers in both potentially malignant and malignant oral lesions CLINICAL SIGNIFICANCE: While smoking and alcohol are known risk factors for oral cancer, a biomarker such as the saliva/stool microbiome profile could help identify a risk indicator or a potential risk factor. Additionally such a biomarker could help identify patients with OPMDs that are likely to undergo malignant transformation.
众所周知,人类微生物群与健康和疾病有关。口腔微生物群与口腔疾病和感染有关,不过基于病变组织学,探索口腔和肠道微生物群与口腔癌之间关系的研究并不多。方法:本研究独特地探索了30名参与者(n = 30)的口腔和肠道微生物群,这些参与者根据组织学分为三组;良性(B)(n = 15)、潜在恶性(PM)(n = 8)和恶性(M)(n = 7)口腔病变。使用鸟枪法宏基因组测序,我们分析了微生物群谱,以确定它们作为口腔恶性肿瘤生物标志物的潜力。结果:在良性和恶性组之间观察到明显不同的肠道微生物谱,口腔唾液中特定微生物的关联,如副流感嗜血杆菌、小韦荣球菌、具核梭杆菌和黏液罗氏菌与恶性肿瘤密切相关。结论:这项探索性研究的数据表明,口腔和肠道微生物群可能作为生物标志物,有助于口腔癌风险的早期检测和评估。关于潜在恶性病变,由于临床和组织学表现差异很大,未来的研究可以将个体口腔潜在恶性疾病(OPMD)作为不同的实体进行研究。需要进一步研究以在潜在恶性和恶性口腔病变中开发确定的生物标志物。临床意义:虽然吸烟和饮酒是已知的口腔癌风险因素,但唾液/粪便微生物群谱等生物标志物可以帮助识别风险指标或潜在风险因素。此外,这样的生物标志物可以帮助识别可能发生恶性转化的OPMD患者。